206 related articles for article (PubMed ID: 16945827)
1. Cutting balloon inflation for drug-eluting stent underexpansion due to unrecognized coronary arterial calcification.
Wilson A; Ardehali R; Brinton TJ; Yeung AC; Lee DP
Cardiovasc Revasc Med; 2006; 7(3):185-8. PubMed ID: 16945827
[TBL] [Abstract][Full Text] [Related]
2. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque.
Otsuka Y; Kasahara Y; Kawamura A
J Invasive Cardiol; 2007 Dec; 19(12):E359-62. PubMed ID: 18180527
[TBL] [Abstract][Full Text] [Related]
3. Comparison of acute and long-term results and underlying mechanisms from sirolimus-eluting stent implantation for the treatment of in-stent restenosis and recurrent in-stent restenosis in patients in whom intracoronary radiation failed as assessed by intravascular ultrasound.
Schiele TM; Rieber J; König A; Leibig M; Erhard I; Theisen K; Siebert U; Klauss V
Am J Cardiol; 2004 Oct; 94(7):917-21. PubMed ID: 15464677
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-eluting stent implantation in a heart transplant recipient.
Tomai F; Gagliardi G; Proietti I
Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
[No Abstract] [Full Text] [Related]
5. High energy excimer laser to treat coronary in-stent restenosis in an underexpanded stent.
Noble S; Bilodeau L
Catheter Cardiovasc Interv; 2008 May; 71(6):803-7. PubMed ID: 18324694
[TBL] [Abstract][Full Text] [Related]
6. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
Honda H; Meguro T; Takizawa K; Isoyama S
J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
Blackman DJ; Porto I; Shirodaria C; Channon KM; Banning AP
Am J Cardiol; 2004 Oct; 94(7):922-5. PubMed ID: 15464678
[TBL] [Abstract][Full Text] [Related]
8. Treatment of long, diffuse in-stent restenosis with sirolimus-eluting stents.
Li SS; So YC; Wong CH; Yiu SF; Chan KT
J Invasive Cardiol; 2004 Feb; 16(2):81-3. PubMed ID: 14760198
[TBL] [Abstract][Full Text] [Related]
9. Very late [corrected] thrombosis of a sirolimus-eluting stent.
Henderson D; Gunalingam B
Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
[TBL] [Abstract][Full Text] [Related]
10. Stent fracture associated with drug-eluting stents: clinical characteristics and implications.
Lee MS; Jurewitz D; Aragon J; Forrester J; Makkar RR; Kar S
Catheter Cardiovasc Interv; 2007 Feb; 69(3):387-94. PubMed ID: 17195203
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Options for In-Stent Restenosis.
Nicolais C; Lakhter V; Virk HUH; Sardar P; Bavishi C; O'Murchu B; Chatterjee S
Curr Cardiol Rep; 2018 Feb; 20(2):7. PubMed ID: 29435779
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions.
Ferri LA; Jabbour RJ; Giannini F; Benincasa S; Ancona M; Regazzoli D; Mangieri A; Montorfano M; Colombo A; Latib A
Catheter Cardiovasc Interv; 2017 Aug; 90(2):E19-E24. PubMed ID: 27862848
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the SafeCut Dual Wire PTCA catheter for the treatment of calcified lesions.
Mori S; Otsuka Y; Kawamura A
J Invasive Cardiol; 2007 Aug; 19(8):E254-6. PubMed ID: 17712217
[TBL] [Abstract][Full Text] [Related]
15. Late drug-eluting stent thrombosis: importance of intravascular ultrasound.
McCann A; MacIsaac A; Whitbourn RJ
Cardiovasc Revasc Med; 2010; 11(1):52-6. PubMed ID: 20129361
[TBL] [Abstract][Full Text] [Related]
16. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
17. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.
Waters RE; Kandzari DE; Phillips HR; Crawford LE; Sketch MH
Catheter Cardiovasc Interv; 2005 Aug; 65(4):520-4. PubMed ID: 15973673
[TBL] [Abstract][Full Text] [Related]
18. No delayed restenosis at 18 months after implantation of sirolimus-eluting stent.
Tanabe K; Degertekin M; Regar E; Ligthart JM; van der Giessen WJ; Serruys PW
Catheter Cardiovasc Interv; 2002 Sep; 57(1):65-8. PubMed ID: 12203931
[TBL] [Abstract][Full Text] [Related]
19. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
[TBL] [Abstract][Full Text] [Related]
20. Stent underexpansion in early drug-eluting stent thrombosis.
Kaneda H; Ma J; Morita T
JACC Cardiovasc Interv; 2009 Aug; 2(8):807. PubMed ID: 19695553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
